Home
About
Overview
Sharing Data
ORCID
Help
History (23)
Pace of Progress in Stroke Thrombolysis: Are Hospitals Running To Stand Still?
Transcription factor CHF1/Hey2 suppresses cardiac hypertrophy through an inhibitory interaction with GATA4.
Helicobacter hepaticus
Impact of abnormal diffusion-weighted imaging results on short-term outcome following transient ischemic attack.
The risk of lymphoma in the treatment of inflammatory bowel disease with immunosuppressive agents.
See All 23 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
The risk of lymphoma in the treatment of inflammatory bowel disease with immunosuppressive agents.
The risk of lymphoma in the treatment of inflammatory bowel disease with immunosuppressive agents. Crit Rev Oncol Hematol. 2005 Oct; 56(1):169-78.
View in:
PubMed
subject areas
Clinical Trials as Topic
Humans
Immunosuppressive Agents
Inflammatory Bowel Diseases
Lymphoma